Bajaj HealthCare Limited (NSE:BAJAJHCARE)
India
· Delayed Price · Currency is INR 516.30
-10.15 (-1.93%)
Jun 13, 2025, 3:29 PM IST
Bajaj HealthCare Revenue
In the fiscal year ending March 31, 2025, Bajaj HealthCare had annual revenue of 5.43B INR with 14.61% growth. Bajaj HealthCare had revenue of 1.54B in the quarter ending March 31, 2025, with 15.36% growth.
Revenue
5.43B
Revenue Growth
+14.61%
P/S Ratio
3.01
Revenue / Employee
5.17M
Employees
1,049
Market Cap
16.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.43B | 691.85M | 14.61% |
| Mar 31, 2024 | 4.73B | -1.72B | -26.69% |
| Mar 31, 2023 | 6.46B | -340.94M | -5.01% |
| Mar 31, 2022 | 6.80B | 229.06M | 3.49% |
| Mar 31, 2021 | 6.57B | 2.46B | 59.96% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Bajaj HealthCare News
- 2 months ago - Bajaj Healthcare shares rise nearly 3% as company acquires GenRx Pharmaceuticals to strengthen manufacturing footprint - Business Upturn
- 4 months ago - Bajaj Healthcare shares rise 5% in weak market as Q3 revenue jumps 13% YoY - Business Upturn
- 4 months ago - Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More - Business Upturn
- 4 months ago - Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India - Business Upturn
- 5 months ago - Bajaj Healthcare shares surge 12% after securing exclusive rights for Magtein® in India - Business Upturn
- 5 months ago - Bajaj Healthcare secures exclusive rights for Magtein® in India from Threotech LLC - Business Upturn
- 6 months ago - Bajaj Healthcare shares surge 2% on new CDMO agreement with UK/EU clients - Business Upturn
- 6 months ago - Bajaj Healthcare signs CDMO contract for 15 new APIs with UK/EU companies - Business Upturn